Full-Time

Medical Director

Palliative Care

Confirmed live in the last 24 hours

Thyme Care

Thyme Care

201-500 employees

Tech-enabled support for cancer patients

Data & Analytics
Healthcare

Compensation Overview

$240k - $255kAnnually

Senior

Remote in USA

The role can be remote or hybrid based in New York City or Nashville.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary

You match the following Thyme Care's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • At least 5 years of post-training clinical experience with the majority in palliative care, preferably caring for oncology patients in the outpatient setting.
  • Unrestricted medical license and willingness to obtain additional state licenses as needed.
  • Experience with video chatting, Google Suite, Slack, electronic health records, or comfort using and learning new technology.
Responsibilities
  • See members for specialty palliative care outpatient appointments via video visits as part of an interdisciplinary team.
  • Oversee and direct interdisciplinary case conferences for members with advanced serious illnesses.
  • Iterate and scale the serious illness program to drive member-centered outcomes and success in partnerships.
  • Collaborate and communicate with external partners about the serious illness program, ensuring optimized workflows for care coordination.
Desired Qualifications
  • Experience working at a startup or tech-forward company.
  • Skilled in juggling multiple tasks and working under pressure without sacrificing organization.
  • Winsome and articulate communicator who builds rapport and great working relationships with members and colleagues.

Thyme Care provides support and guidance specifically for cancer patients, aiming to ensure they receive high-quality care throughout their treatment journey. The company integrates with existing clinical teams to offer continuous support, utilizing technology and oncology expertise to enhance patient care. Their services include personalized guidance for patients and acting as an extension of healthcare providers' clinical teams, aligning incentives across the healthcare system. What sets Thyme Care apart from competitors is its focus on reducing the total cost of care through targeted interventions, which have been shown to lower inpatient spending and visits. The goal of Thyme Care is to deliver high-quality cancer care while also making it more affordable for patients and healthcare providers.

Company Size

201-500

Company Stage

Series C

Total Funding

$131.3M

Headquarters

Nashville, Tennessee

Founded

2020

Simplify Jobs

Simplify's Take

What believers are saying

  • Thyme Care projects 4x growth in 2025 due to increased demand.
  • The company secured $95M funding to expand its value-based care platform.
  • Thyme Care's partnerships enhance its national expansion and service reach.

What critics are saying

  • Increased competition may threaten Thyme Care's market share.
  • Rapid expansion could lead to operational inefficiencies and resource strain.
  • Changes in partnerships or healthcare policy could impact Thyme Care's model.

What makes Thyme Care unique

  • Thyme Care offers a tech-enabled, patient-centric oncology care model.
  • The company integrates with clinical teams for 24/7 cancer care support.
  • Thyme Care's value-based model reduces inpatient spend and visits significantly.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Remote Work Options

Company Equity

Growth & Insights and Company News

Headcount

6 month growth

-4%

1 year growth

-4%

2 year growth

-6%
PR Newswire
Dec 17th, 2024
Thyme Care Projects 4X Growth In 2025 As Demand For Value-Based Oncology Care Surges; New Partnerships Bring Comprehensive Cancer Care Support To Over 40,000 Patients Across The Nation

Oak Street Health, EmblemHealth, Vytalize Health, and several large national health plans recognize Thyme Care's patient-centric navigation and deep provider relationships as a leading value-based model that delivers on the promise of better care at lower costsThyme Care generates savings and improves the cancer experience, fueling its national expansion across Medicare Advantage, commercial health plans, employers, provider groups, and CMS's Enhancing Oncology ModelThyme Care Oncology Partners (TCOP) doubles the number of oncologists in its network since launching in March; more than 850 oncologists represented from every major managed service organization now part of the platformNASHVILLE, Tenn., Dec. 17, 2024 /PRNewswire/ -- Thyme Care today announced new strategic partnerships across the cancer care continuum, enabling the company to achieve 4x year-over-year growth in 2025. With this momentum, Thyme Care expects to bring comprehensive cancer care support services to over 40,000 people with cancer.The cancer care system is nearing a financial and logistical breaking point, strained by systemic inefficiencies and gaps in care that burden patients, providers, and payers alike. Patients and caregivers struggle to navigate a complex and siloed healthcare ecosystem, and often experience barriers to care once they leave the physician's office. Oncologists, regardless of whether they practice in the community or a hospital setting, are not incentivized in the current fee-for-service environment to provide value-based care. These challenges inflate costs for everyone in the care continuum, bringing the entire system closer to a breaking point

Rama On Healthcare
Jul 17th, 2024
Palliative Provider Thyme Care Secures $95M in Funding Round

In May, Thyme Care launched a new palliative care telehealth offering, branded as Enhanced Supportive Care.

MedCity News
Jul 17th, 2024
Thyme Care Raises $95M To Advance Cancer Care

Concord Health Partners invested in Thyme Care for its ability to improve patient care and reduce costs.

Hit Consultant
Jul 17th, 2024
Thyme Care Secures $95M To Expand Value-Based Cancer Care Platform

What You Should Know:– Thyme Care, a leading value-based cancer care enabler raises $95M in funding capital led by Concord Health Partners, with participation from existing investors including CVS Health® Ventures, Town Hall Ventures, a16z Bio + Health, AlleyCorp, Echo Health Ventures, Foresite Capital, and new investor SignalFire. The funding brings Thyme Care’s total funding to $178M.– Thyme Care is a value-based cancer care enabler focused on improving patient outcomes and reducing healthcare costs. The new funding will fuel Thyme Care’s expansion into new markets, deepen existing partnerships, and enhance its clinical value-based care model.Addressing the Cancer Care CrisisThe cancer care landscape is marked by escalating costs, fragmented care, and significant disparities in patient outcomes. Drug costs alone can account for up to 70% of total care expenses, with many life-saving therapies exceeding $200,000 annually. Patients often face overwhelming financial burdens, gaps in support, and a lack of care coordination.Thyme Care is addressing these challenges with a comprehensive approach that focuses on reducing costs, improving outcomes, and enhancing the patient experience.Thyme Care’s Impactful SolutionThyme Care’s value-based care model includes:24/7 specialized cancer care navigation: Guiding patients through complex treatment journeys.Guiding patients through complex treatment journeys. Advanced technology and data insights: Optimizing care delivery and identifying areas for improvement.Optimizing care delivery and identifying areas for improvement

Finsmes
Jul 16th, 2024
Thyme Care Raises $95M in Series C Funding

Thyme Care, a Nashville, TN-based value-based cancer care enabler, raised $95M in Series C funding